tiprankstipranks
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF

MediPharm Labs (MEDIF) Stock Price & Analysis

405 Followers

MEDIF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.04 - $0.08
Previous Close$0.06
Volume32.64K
Average Volume (3M)111.73K
Market Cap
$25.12M
Enterprise Value$17.60M
Total Cash (Recent Filing)C$12.95M
Total Debt (Recent Filing)C$2.72M
Price to Earnings (P/E)-2.4
Beta0.71
May 13, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding404,048,948
10 Day Avg. Volume138,842
30 Day Avg. Volume111,726
Standard Deviation0.19
R-Squared0.10
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.63
Price to Sales (P/S)143.81
Price to Cash Flow (P/CF)N/A
P/FCF Ratio57.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

19.34%0.00%0.90%79.76%
19.34% Insiders
0.90% Other Institutional Investors
79.76% Public Companies and
Individual Investors

MEDIF FAQ

What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was $0.04 and its highest was $0.08 in the past 12 months.
    What is MediPharm Labs’s market cap?
    Currently, no data Available
    When is MediPharm Labs’s upcoming earnings report date?
    MediPharm Labs’s upcoming earnings report date is May 13, 2024 which is in 24 days.
      How were MediPharm Labs’s earnings last quarter?
      MediPharm Labs released its earnings results on Mar 27, 2024. The company reported -$0.007 earnings per share for the quarter, the consensus estimate of -$0.007 by $0.
        Is MediPharm Labs overvalued?
        According to Wall Street analysts MediPharm Labs’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MediPharm Labs pay dividends?
          MediPharm Labs does not currently pay dividends.
          What is MediPharm Labs’s EPS estimate?
          MediPharm Labs’s EPS estimate is >-$0.01.
            How many shares outstanding does MediPharm Labs have?
            MediPharm Labs has 401,280,760 shares outstanding.
              What happened to MediPharm Labs’s price movement after its last earnings report?
              MediPharm Labs reported an EPS of -$0.007 in its last earnings report, expectations of -$0.007. Following the earnings report the stock price went down -14.286%.
                Which hedge fund is a major shareholder of MediPharm Labs?
                Currently, no hedge funds are holding shares in MEDIF
                ---

                MediPharm Labs Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                8.62%
                12-Months-Change

                Fundamentals

                Return on Equity
                -23.79%
                Trailing 12-Months
                Asset Growth
                0.31%
                Trailing 12-Months

                Company Description

                MediPharm Labs

                MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.
                ---

                MEDIF Earnings Call

                Q4 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Cronos Group
                OrganiGram Holdings
                Canopy Growth
                Green Thumb Industries
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis